Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1432-0584

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia ; volume:100 ; number:9 ; day:26 ; month:7 ; year:2021 ; pages:2143-2154 ; date:9.2021
Annals of hematology ; 100, Heft 9 (26.7.2021), 2143-2154, 9.2021

Creator: Grainger, John D.
Kühne, Thomas
Hippenmeyer, Jane
Cooper, Nichola

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00277-021-04590-0

URN: urn:nbn:de:101:1-2021103122331309488915

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:26 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Grainger, John D.
Kühne, Thomas
Hippenmeyer, Jane
Cooper, Nichola
SpringerLink (Online service)

Other Objects (12)

Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice

ESPED survey on newly diagnosed immune thrombocytopenia in childhood: how much treatment do we give?

Association between P-Selectin Autoantibody Positive and Response to Steroid Treatment in Newly Diagnosed Immune Thrombocytopenia Patients

Prevalence of Diagnosed Adult Immune Thrombocytopenia in the United Kingdom

Immune thrombocytopenia (ITP)

Biomarkers for immune thrombocytopenia

T cell immune abnormalities in immune thrombocytopenia

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension

Differential Expression of MiR-106b-5p and MiR-200c-3p in Newly Diagnosed Versus Chronic Primary Immune Thrombocytopenia Patients Based on Systematic Analysis

Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia

Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice

ESPED survey on newly diagnosed immune thrombocytopenia in childhood: how much treatment do we give?

Association between P-Selectin Autoantibody Positive and Response to Steroid Treatment in Newly Diagnosed Immune Thrombocytopenia Patients

Prevalence of Diagnosed Adult Immune Thrombocytopenia in the United Kingdom

Immune thrombocytopenia (ITP)

Biomarkers for immune thrombocytopenia

T cell immune abnormalities in immune thrombocytopenia

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension

Differential Expression of MiR-106b-5p and MiR-200c-3p in Newly Diagnosed Versus Chronic Primary Immune Thrombocytopenia Patients Based on Systematic Analysis

Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia

Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice

ESPED survey on newly diagnosed immune thrombocytopenia in childhood: how much treatment do we give?

Association between P-Selectin Autoantibody Positive and Response to Steroid Treatment in Newly Diagnosed Immune Thrombocytopenia Patients

Prevalence of Diagnosed Adult Immune Thrombocytopenia in the United Kingdom

Immune thrombocytopenia (ITP)

Biomarkers for immune thrombocytopenia

T cell immune abnormalities in immune thrombocytopenia

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension

Differential Expression of MiR-106b-5p and MiR-200c-3p in Newly Diagnosed Versus Chronic Primary Immune Thrombocytopenia Patients Based on Systematic Analysis

Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice

ESPED survey on newly diagnosed immune thrombocytopenia in childhood: how much treatment do we give?

Association between P-Selectin Autoantibody Positive and Response to Steroid Treatment in Newly Diagnosed Immune Thrombocytopenia Patients

Prevalence of Diagnosed Adult Immune Thrombocytopenia in the United Kingdom

Immune thrombocytopenia (ITP)

Immune thrombocytopenia (ITP)

Immune thrombocytopenia (ITP)

Biomarkers for immune thrombocytopenia

T cell immune abnormalities in immune thrombocytopenia

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension

Differential Expression of MiR-106b-5p and MiR-200c-3p in Newly Diagnosed Versus Chronic Primary Immune Thrombocytopenia Patients Based on Systematic Analysis

Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia

Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice

ESPED survey on newly diagnosed immune thrombocytopenia in childhood: how much treatment do we give?

Association between P-Selectin Autoantibody Positive and Response to Steroid Treatment in Newly Diagnosed Immune Thrombocytopenia Patients

Prevalence of Diagnosed Adult Immune Thrombocytopenia in the United Kingdom

Immune thrombocytopenia (ITP)

Immune thrombocytopenia (ITP)

Immune thrombocytopenia (ITP)

Biomarkers for immune thrombocytopenia

T cell immune abnormalities in immune thrombocytopenia

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension

Differential Expression of MiR-106b-5p and MiR-200c-3p in Newly Diagnosed Versus Chronic Primary Immune Thrombocytopenia Patients Based on Systematic Analysis

Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia

Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice

ESPED survey on newly diagnosed immune thrombocytopenia in childhood: how much treatment do we give?

Association between P-Selectin Autoantibody Positive and Response to Steroid Treatment in Newly Diagnosed Immune Thrombocytopenia Patients

Prevalence of Diagnosed Adult Immune Thrombocytopenia in the United Kingdom

Immune thrombocytopenia (ITP)

Immune thrombocytopenia (ITP)

Immune thrombocytopenia (ITP)

Biomarkers for immune thrombocytopenia

T cell immune abnormalities in immune thrombocytopenia

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension

Differential Expression of MiR-106b-5p and MiR-200c-3p in Newly Diagnosed Versus Chronic Primary Immune Thrombocytopenia Patients Based on Systematic Analysis

Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia

Related objects

Reset password